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Public health surveillance with electronic medical records: at risk of
surveillance bias and overdiagnosis
Public health surveillance consists in the systematic collection,
analysis and interpretation of data, closely integrated with the
timely dissemination and use of these data to help prevent and
control diseases and injuries.1 Surveillance is traditionally
conducted with data tailored to address a specific health problem,
for instance, data on risk behaviours from periodic health surveys or
data on cancers collected in dedicated registries. These data and
methods of collection are ‘designed’ for specific surveillance
activities.2
In the past two decades, methods of surveillance have radically
changed with the development of information technology, making
easier the collection of data for public health surveillance.3 In
particular, data from health care providers have become highly
accessible through electronic medical records (EMRs), which offers
fantastic opportunities for the surveillance of several conditions.
Surveillance of chronic diseases using EMRs
EMR is a digital record of patient’s health and health care from
hospitals, nursing homes, physician’s offices or pharmacies.3 All
kinds of medical events are recorded in EMRs, being diagnoses,
laboratory results, treatments, drug prescriptions, vital signs or
clinical outcomes. EMRs increase the availability of clinical informa-
tion, can help decision making and improve quality and efficiency of
care. Furthermore, shared EMRs are cardinal for the evolution of
health professionals’ practices in the care of chronic diseases.4
EMRs are designed to support health care providers’ activities at
the point of care but are not primarily designed for surveillance.
Nevertheless, the large amounts of raw data—also qualified as
‘organic’2—that can be retrieved from EMRs are highly attractive
for the surveillance of several conditions, and of chronic diseases in
particular. For instance, EMR-based surveillance system could allow
identify new diabetes cases and also help assess the process, quality
and costs of care of these patients.5 No other tool has the potential to
provide such comprehensive and timely information on chronic
diseases.
There are, however, limitations to what can be expected from
EMR-based surveillance systems due to data misreporting and to
the lack of standardization on how health events are defined and
recorded in EMRs. In particular, two related issues challenge
the interpretation of EMRs data, that is, ‘surveillance bias’ and
‘overdiagnosis’.
Surveillance bias
Surveillance bias occurs when a condition is searched with differen-
tial intensity according to the setting of care or the type of patients.6
For instance, detection and treatment of deep vein thrombosis
(DVT), a preventable complication of major surgery, is recom-
mended. Suppose that, following a quality improvement policy,
systematic screening of DVT by duplex ultrasound is conducted
among all patients having major surgery in the hospital A. Thanks
to systematic screening, asymptomatic (hence less severe) cases of
DVT are found in addition to symptomatic cases. Therefore, the rate
of DVT—easily computed thanks to EMRs—will be high in this
hospital.6 In the hospital B, where no systematic screening of DVT
is conducted, only symptomatic cases will be identified, and the rate
of DVT will be lower. The rate difference between both hospitals is
solely the result of a surveillance bias: it does not reveal any
difference in the epidemiology of DVT, in quality of care or in
prevention policies between hospitals.
Surveillance bias is common with adverse effects of drug
treatments, complications after a medical procedure or hospital-
acquired conditions, e.g. nosocomial infections, for which differen-
tial surveillance activity occurs according to the care setting. Data
on these events are of major interest for the assessment of quality of
care and can be, actually, easily retrieved from EMRs.
An epidemic of diagnoses due to
overdiagnosis
Overdiagnosis also challenges the interpretation of EMRs data. It
occurs when asymptomatic people are diagnosed with a condition
not associated with a substantial risk of adverse outcomes or for
which no intervention reduces substantially this risk.7,8 Many
conditions can be overdiagnosed through screening, incidental
findings or by widening the boundaries of treatable conditions.
Thus, lowering the thresholds of blood glycaemia level to diagnose
diabetes or pre-diabetes can lead to overdiagnosis.9
One consequence of lowering thresholds is that patients are now
diagnosed with conditions that are less harmful compared with the
same conditions diagnosed previously. Hence, a diagnosis of hyper-
tension set for a blood pressure >140/90 mmHg is associated with a
lower risk of disease than a diagnosis set for a blood pressure >160/
100 mmHg. Furthermore, the combination of screening and of
lowering thresholds to define conditions sustains a vicious circle,
leading eventually to an epidemic of diagnoses (figure 1).7 This
epidemic of diagnoses may not match any epidemic of diseases.
For instance, an increasing share of the population is treated
for hypercholesterolaemia. This increase can be easily documented
using EMRs from hospitals, physicians’ files or pharmacy databases.
Nevertheless, this trend does not imply an increase in the frequency
of people with risky blood lipid profile. On the contrary, favourable
trends in blood lipids have been observed in high-income countries,
and such trends were not explained by improved treatments. The
increase in the prevalence of hypercholesterolaemia is due to
the higher proportion of persons screened and treated, and to the
lowering of blood lipid thresholds for initiating treatment.
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Figure 1 Screening and lowering thresholds to define conditions
requiring intervention lead to an increasing number of persons
diagnosed with the condition and, eventually, an epidemic of
diagnoses (adapted from Welch7)
The problem is that diagnoses reported in EMRs most often do not
capture the changes in the way hypercholesterolaemia is defined or
treated, which blurs the analysis of genuine trends in risky blood
lipid profile.
Conclusion: high accessibility vs. high
quality?
With the development of information technology and EMRs, data
from health care providers have become highly accessible, which
offers fantastic opportunities for the surveillance of chronic diseases.
Nevertheless, the high accessibility does not imply a high quality of
data, on the contrary. EMR data should be used with caution: they,
indeed, do not speak for themselves. As underlined, surveillance bias
and overdiagnosis recall that data from health care providers convey
complex health events not defined in a standardized way. At the dawn
of the digital era, providing useful information from health care
providers for public health surveillance requires more than ever a
critical eye on EMR-based surveillance system.
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All data and all diagnoses deserve a critical eye
I agree completely with the conclusion of this article that ‘providing
useful information from health care providers for public health
surveillance requires more than ever a critical eye on EMR-based
surveillance systems’. But at the same time I advocate ‘a critical eye’
for everything and certainly for all data. We can easily be bewitched
by numbers into thinking that they have a precision and validity that
we never expect from words, but numbers need to be treated as
cautiously as words. Where do they come from? Was there
collection quality assured? Were data missing? What biases are at
work? Are they timely? If they have been ‘adjusted’, how well have
they been adjusted?
The Need for a Critical Eye
I am writing this in a country (the UK) and on a day (17 March
2013) when data collected from routine systems in hospitals are on
the front page of our newspapers.1 Professor Brian Jarman says that
20 000 people may have died prematurely in a few English hospitals
and that the government ignored the signals from the data.1 Jarman
has for many years been producing hospital standardized mortality
ratios (HSMRs), ‘the ratio of the observed to expected deaths,
multiplied by 100, with expected deaths derived from statistical
models that adjust for available case mix factors such as age and
comorbidity’.2
HSMR is on our front pages because a high ratio signalled that
something was badly wrong in Mid Staffordshire National Health
Service (NHS) Trust, a hospital in the Midlands of England. The
high ratio together with other signals of poor performance led to the
discovery that care in the hospital had fallen way below acceptable
standards and that there had been perhaps 2000 excess deaths. For
many people, this ‘proved’ the usefulness of the HSMR and has led
to a call for all other hospitals with high HSMRs to be investigated.
But, as those who developed the HSMR argue themselves, the
ratios need to be interpreted with a critical eye.2 There are
problems with the numerator, denominator, risk modelling, inter-
pretation and coding, and some epidemiologists have argued that
they are so misleading as to be useless.3,4
All of this matters greatly because several hospitals are now being
investigated because of persistently high HSMRs and because one of
the main ways that the NHS, currently undergoing yet another re-
organization, plans to regain its reputation is through making trans-
parent data about everything that is happening in the NHS. We can
at least know most of the time whether patients are dead or alive
(although not always accurately), but when it comes to subtler
diagnoses, there is much room for misinterpretation, as Chiolero
and others show. The expectation in the NHS is that many of the
data will come from electronic medical records in real time. Many
critical eyes will be needed.
Overdiagnosis and Moving from Treatment
to Prevention
The great epidemiologist Geoffrey Rose, who had a gift for sound
bites, said that there is no disease you either have or do not have,
except perhaps rabies and sudden death. With everything else, you
might have a little of it or a lot of it. So disease thresholds are
arbitrary and can be moved backwards and forwards. Defining
normal is also famously difficult. Using a definition of normal as
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